Journal
BIOELECTROCHEMISTRY
Volume 137, Issue -, Pages -Publisher
ELSEVIER SCIENCE SA
DOI: 10.1016/j.bioelechem.2020.107633
Keywords
Gold nanostars; CD133; Electrochemiluminescence; Carbon nitride nanosheets; Cancer stem cells; Membrane biomarker
Funding
- National Research Foundation of Korea [NRF-2018R1A2B3001246]
Ask authors/readers for more resources
Gold nanostars were utilized to enhance the electrochemiluminescence emission from graphitic carbon nitride nanosheets for the detection of CD133 peptide. The biosensor exhibited superior stability and sensitivity, with an additional enhancement due to the localized surface plasmon resonance effect of gold nanostars. The designed biosensor showed promising results in detecting CD133 peptide in spiked serum samples.
Gold nanostars (AuNSs) demonstrate an intense electromagnetic field around tip of branches. In this research, we employed AuNSs-enhanced electrochemiluminescence (ECL) emission from graphitic carbon nitride nanosheets (g-CN nanosheets) to detect CD133 peptide as a cancer stem cell membrane biomarker. In this biosensor, the g-CN nanosheets were decorated with AuNSs (AuNSs@g-CN nanosheets). AuNSs@g-CN nanosheets exhibited strong and stable cathodic ECL emission compared to that of pure g-CN nanosheets. The ECL intensity from the AuNSs@g-CN nanosheets was over 30% higher than that of spherical gold nanoparticles (spherical AuNPs) decorated g-CN nanosheets. The additional ECL enhancement of AuNSs was due to the localized surface plasmon resonance (LSPR) effect located around multiple branch tips of AuNSs. The RSD of ECL curves intensities, obtained from successive potential scans for 10 cycles, were less than 4%, indicating the superior stability of the AuNSs@g-CN nanosheets. Under optimum conditions, the ECL intensity of GCE/AuNSs@g-CN nanosheets/anti-CD133 decreased linearly with CD133 peptide concentration in the range of 0.05-100 ng mL(-1). The LOD achieved was 0.257 ng mL(-1) (S/N = 3). The applicability of the designed biosensor in real samples was examined through the determination of CD133 peptide in spiked serum samples, from which satisfactory results were obtained. (C) 2020 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available